| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $107.9M | -2.2% |
| R&D Expense | $157.1M | +17.4% |
| SG&A Expense | $88.4M | +33.3% |
| Operating Income | -$137.6M | -53.1% |
| Pre-tax Income | -$105.3M | -50.3% |
| Income Tax | $2.1M | +212.1% |
| Net Income | -$107.3M | -51.9% |
| EPS (Basic) | -$2.00 | -36.1% |
| EPS (Diluted) | -$2.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.7M | -73.2% |
| Short-term Investments | $481.7M | +56.7% |
| Current Assets | $599.3M | -16.3% |
| Total Assets | $711.3M | -13.8% |
| Current Liabilities | $125.4M | +6.1% |
| Total Liabilities | $256.5M | -24.5% |
| Stockholders' Equity | $454.8M | -6.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83.5M | -140.2% |
| Capital Expenditures | $13.4M | -37.3% |
| Investing Cash Flow | -$183.0M | -18.5% |
| Financing Cash Flow | -$24.1M | -108.6% |
| Free Cash Flow | -$96.9M | -152.1% |
| -36.1% |